Page last updated: 2024-10-22

theophylline and Fractures, Bone

theophylline has been researched along with Fractures, Bone in 2 studies

Fractures, Bone: Breaks in bones.

Research Excerpts

ExcerptRelevanceReference
"The therapeutic strategy is much the same as for younger asthmatics but certain aspects take on greater importance: concerns about osteoporosis with long-term corticosteroid therapy (both oral and inhaled), the risk of arrhythmias with beta-2 adrenergic drugs and the significant side-effects of theophylline justifies, in difficult cases, consideration of anti-cholinergic and/or anti-leukotriene therapy."4.82[Asthma in the elderly]. ( Radenne, F; Tonnel, AB; Verkindre, C, 2003)
"Theophylline treatment resulted in a time-dependent (at 4- and 8 weeks) bone loss."1.43Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats. ( Bhadauria, S; Chattopadhyay, N; China, SP; Gayen, JR; Godbole, MM; Gupta, SK; Hossain, Z; Khan, K; Mandalapu, D; Mittal, M; Pal, S; Porwal, K; Sanyal, S; Sharma, VL; Shrivastava, R; Taneja, I; Trivedi, AK; Wahajuddin, M, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pal, S1
Khan, K1
China, SP1
Mittal, M1
Porwal, K1
Shrivastava, R1
Taneja, I1
Hossain, Z1
Mandalapu, D1
Gayen, JR1
Wahajuddin, M1
Sharma, VL1
Trivedi, AK1
Sanyal, S1
Bhadauria, S1
Godbole, MM1
Gupta, SK1
Chattopadhyay, N1
Radenne, F1
Verkindre, C1
Tonnel, AB1

Reviews

1 review available for theophylline and Fractures, Bone

ArticleYear
[Asthma in the elderly].
    Revue des maladies respiratoires, 2003, Volume: 20, Issue:1 Pt 1

    Topics: Adolescent; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonist

2003

Other Studies

1 other study available for theophylline and Fractures, Bone

ArticleYear
Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats.
    Toxicology and applied pharmacology, 2016, Mar-15, Volume: 295

    Topics: Animals; Apoptosis; Biomarkers; Bone Diseases, Metabolic; Bone Marrow; Bone Regeneration; Calcifedio

2016